Telemedicine market to surpass USD 930.31 billion by 2030 from USD 37.69 billion in 2020 at a CAGR of 37.80% in the coming years, i.e., 2021-30.

Product Overview
Telemedicine is a method of diagnosing and treating medical conditions through the use of telecommunications networks. Information can be delivered to consultant doctors via satellite connection in the form of digital data packs using a telemedicine system that includes the required communications for medical imaging. Telemedicine physicians can use this information to evaluate patient data and prescribe medications in real-time. Telemedicine has the potential to benefit those living in distant villages and rural locations while also lowering healthcare costs. It improves efficiency by allowing shared health professional personnel to better supervise illnesses.

Market Highlights
Telemedicine market is expected to project a notable CAGR of 37.80% in 2030
Factors such as the growing population, the need to expand healthcare access, the rising prevalence of chronic diseases and conditions, a physician shortage, advancements in telecommunications, government support, increasing awareness, and increasing technology adoption are all driving growth in the telehealth and telemedicine market.

Recent highlights in the Telemedicine market
In 2020, Philips released the Avalon CL Fetal and Maternal Pod and Patch for remote monitoring in the United States, Europe, Australia, New Zealand, and Singapore.

In 2020, The partnership between Koninklijke Philips and the American Telemedicine Association (ATA) (US) helped to promote the usage of telehealth in acute, post-acute, and home care settings.

Telemedicine Market: Segments
segment to grow with the highest CAGR during 2020-30
Telemedicine market is segmented by Application into Teleradiology, Tele-consultation, Tele-ICU, Tele-stroke, Tele-psychiatry, Tele-dermatology, and Other Applications. Among these, the Teleradiology category dominated the market in 2020. Due to reasons such as a rise in imaging procedures, teleradiology workflow adoption by healthcare providers, and the simplification and regulation of teleradiology operations, the teleradiology sector led the telemedicine market and accounted for the highest revenue share in 2020.

Patients segment to grow with the highest CAGR during 2020-30
Telemedicine market is segmented by End-User into Providers, Payers, Patients, and Other End Users. In 2020, the patient sector led the telemedicine market, accounting for the majority of revenue. Patients use telemedicine services for a variety of reasons, ranging from minor to major health concerns to emergency circumstances. Insurance firms that pay telemedicine service providers on behalf of patients make up the payers segment. Not all telemedicine services are currently covered by insurance. Patients must visit clinics to complete a session, despite the fact that Medicare supports limited telemedicine services in remote regions. In the future years, this segment is projected to grow significantly.

Market Dynamics
Drivers
Technology adoption in the wake of COVID-19
In the wake of the pandemic, demand for healthcare services and technologies reached an all-time high. Telemedicine, chatbots, and robots are all being used to assist gather information, reassure the public, treat patients, make diagnoses, and even create future vaccinations. Given the global lack of hospital beds and healthcare personnel, the potential of telemedicine has been stressed. Players in the telehealth industry are concentrating on developing COVID-19-based solutions to help hospitals and healthcare providers.

Advanced and versatile technology
Telemedicine is the most versatile technology for providing health education, information, and treatment to those who reside far away. Advanced patient-centered treatment and expanded access to remote places are now available because to technological advancements. It also aids in the reduction of ER visits and hospitalization rates, boosting the market growth.

Restraint
Healthcare Fraud
In the field of telehealth and telemedicine, healthcare fraud is a significant topic. A patient or a physician might be exploited in a variety of ways. For example, the physician’s identity and accounts can be used to get money from the insurance company, or non-eligible or non-listed institutional providers can utilize faulty coding and billing to submit bogus claims.

Telemedicine Market: Key Players
MDlive Inc.

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

SteadyMD Inc.
Maven, Inc.
iCliniq
HealthTap, Inc.
BioTelemetry, Inc.
American Well
CVS Health
Synapse Medicine
Practo

Telemedicine Market: Regions
Telemedicine market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and the Middle East, and Africa. Telemedicine market in North America held the largest market share in the year 2019. The increased prevalence of chronic diseases, the need to decrease healthcare costs, and the growing overall and senior population are all contributing to this region’s substantial proportion of the telemedicine market in this region. However, Due to the prevalence of chronic illnesses and hospital overcrowding, the Asia Pacific market is anticipated to grow at the fastest rate over the forecast period.

Telemedicine market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – China, Japan, Australia, and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Telemedicine report also contains analysis on:
Telemedicine Segments:
By Component
Software & services
Hardware
By Mode of delivery
Cloud-based
On-Premise
By Application
Teleradiology
Tele-consultation
Tele-ICU
Tele-stroke
Tele-psychiatry
Tele-dermatology
Other Applications
By End-User
Providers
Payers
Patients
Other End Users
Telemedicine Market Dynamics
Telemedicine Market Size
Supply & Demand
Current Market Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints

Telemedicine Market Report Scope and Segmentation

Report Attribute Details
Market size value in 2021 USD 51.85 billion
Revenue forecast in 2030 USD 930.31 billion
Growth Rate CAGR of 37.80% from 2021 to 2030
Base year for estimation 2020
Quantitative units Revenue in USD billion and CAGR from 2021 to 2030
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Component, Mode of Delivery, Application, End-user, and Region
Regional scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
Key companies profiled MDlive Inc, SteadyMD Inc, Maven Inc, iCliniq, HealthTap Inc., BioTelemetry Inc, American Well, CVS Health, Synapse Medicine, Practo, and Other Prominent Players.

Frequently Asked Questions
How big is the Telemedicine market?
What is the Telemedicine market growth?
Which segment accounted for the largest Telemedicine market share?
Who are the key players in the Telemedicine market?
What are the factors driving the Telemedicine market?

The post Global Telemedicine Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030 first appeared on CRI Report.

Market Segmentation

• Product Type (AI-Integrated Hardware and Software and Services)
• Technology (Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, and Others)
• Application (Medical Imaging and Diagnosis, Data Management, Telemedicine, Remote Monitoring and Lifestyle Management, Robot-Assisted Surgery, Drug Discover and Clinical Trials, Virtual Assistance, and Others)
• End User (Patients, Healthcare Providers, Academic Institutes and Research Centers, Pharmaceutical Companies, Healthcare Insurance, and Others)

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, Italy, U.K., Spain and Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, South Korea and Rest-of-Asia-Pacific
• Rest-of-the-World – Brazil, Mexico, Argentina and Rest-of-Rest-of-the-World

Growth Drivers

• Growing Need for Patient-Centric Care
• Growing Applications of AI in Healthcare Informatics
• Shortage of Healthcare Workforce
• Increasing Complexities of Clinical Decision Making
• Progress in Healthcare IT

Market Challenges

• Lack of Clearly Defined Regulations
• Data Security and Privacy Concerns
• Barriers to Physician’s Adoption of AI
• Legal Implications of AI Systems

Market Opportunities

• Capitalizing on Unmet Clinical Demand
• Enabling Care At-Home: Remote Monitoring
• Leveraging Rapid Development in Deep Learning
• Unlocking the Combined Potential of AI and Robotics

Key Companies Profiled

Activ Surgical, Inc., Atomwise, Inc., Babylon Health, BenevolentAI, Butterfly Network, Inc., Freenome, General Electric Company, International Business Machines Corporation (IBM), Koninklijke Philips N.V., Nuance Communications, Inc., Nvidia Corporation, Olive, Siemens Healthineers AG, Viz.ai, Inc., and Zebra Medical Vision Ltd.

Key Questions Answered in this Report:

• What are the key regulations governing AI adoption in healthcare across various regions?
• Which start-ups received significant funding in 2020?
• What has been the impact of the COVID-19 pandemic on global AI in healthcare market?
• What is the anticipated futuristic impact of COVID-19 on AI adoption in the global healthcare market?
• What are the opportunities for AI healthcare startups in healthcare sector during the COVID-19 pandemic?
• Who are the leading players in global AI in healthcare market?
• What are the key business models prevalent in global AI in healthcare market?
• What type of products are anticipated to be launched during the forecast period 2021-2030?
• What are the key market drivers, restraints, and growth opportunities for the market?
• What was the market size for the various product types in the global AI in healthcare market in 2020? How are the product types anticipated to grow during the forecast period 2021-2030?
• What was the market size for various AI-enabled applications in healthcare in 2020? Which application is anticipated to grow with the highest CAGR during the forecast period 2021-2030?
• What was the market size of AI technologies, such as machine learning, deep learning, natural language processing, and computer vision in 2020? How are the technologies anticipated to grow during the forecast period, 2021-2030?
• Which region contributes the major share to the global AI in healthcare market? Which region holds significant growth potential during the forecast period 2021-2030?

Key USPs of the Report

Following are some of the key contents of the report:

• Funding Scenario

This section encompasses a description of the current funding landscape in the global AI in healthcare space for key players.

• Technology Readiness Index

This section is intended to aid the readers in identifying novel technology opportunities.

• Business Model Analysis

This section comprises information on the key business models deployed in the market by leading players.

• Impact of COVID-19

This section of the report encompasses the following:
o Impact on AI adoption
o Future impact (Short-, mid-, and long-term)
o Key developments during the COVID-19 pandemic

In addition, the report provides:

• A detailed analysis and growth forecast (2021-2030) for different market segments
• Recent developments and trends in the global market landscape
• Factors promoting and inhibiting the market growth
• Case studies to assess the delivery models and strategies adopted by some of the highly funded players in the market

Expert Quote

“At present, many companies refrain from venturing into this field as in many cases, companies pursue R&D without knowing whether their concept makes for a viable business model. Currently, most of the companies have their own unique model. However, four years down the line, the competition will be more intense, and the market would witness a repetition of existing services and offerings”.

Scope of the Global AI in Healthcare Market

The purpose of the study is to enable the reader to gain a holistic view of the global AI in healthcare market, by each of the segments mentioned above.

The report constitutes an in-depth analysis of the global AI in healthcare market, including a thorough analysis of the applications. The study also provides market and business-related information on various products, applications, technologies, and end users. The report considers integrated devices, software, and services related to AI in healthcare.

The post Global AI in Healthcare Market: Analysis and Forecast, 2021-2030 first appeared on CRI Report.

Market Analysis
The telemedicine fills in as an arrangement for different remote clinical administrations, which bring about with the assistance of ongoing, two-route correspondence between the patient and the healthcare center. This includes the utilization of an assortment of electronic, sound, and visual methods. An expanding selection of electronic healthcare record (EHR) or the electronic medical record (EMR) is a noteworthy driver for market development amid the estimate time period.

Furthermore, the growing occurrence of chronic diseases like cancer, diabetes, besides others and the lack of good physicians and good health care services in few regions is boosting the demand of the global telemedicine market. This type of e-hospital facility gives online client benefit from the teleconsulting process to global transfer and treatment. Nonetheless, the surprising expense of executing telemedicine frameworks, i.e., EMR and EHR and requirement for telemedicine training pursued by stringent government directions relating to telemedicine are evaluated to hamper the market development amid the forecast period.

Market Segmentation
The global telemedicine market is divided on the basis of its service type, deployment, component, application, end user and regional demand. Based on its service type, the market is segmented into telepharmacy, telenursing, teleradiology, tele-oncology, teledermatology, others. On the basis of the component, the global market is sectioned into hardware and software. Based on its deployment, the market is classified into on premises and cloud-based. On the basis of its application, the global telemedicine market is segmented into ophthalmology, cardiology, psychiatry, dermatology, radiology, and others. Based on its end user, the market is bifurcated into clinics, hospitals, and home care.

Regional Analysis
The global telemedicine market has been spanned across global regions like Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa.

Key Players
The industry players for the global telemedicine market include companies like AMD Global Telemedicine, Inc., CareClix, CardioNet, Cerner Corporation, GENERAL ELECTRIC, Cisco, IBM Corporation, Iris Telehealth, Intel Corporation, Koninklijke Philips N.V., TeleVital, Aerotel Medical Systems, Medtronic, SHL Telemedicine, Allscripts Healthcare Solutions, Honeywell Lifesciences, Cardiocom, Tunstall Healthcare, Medvivo Group Ltd., Care Innovations, Aerotel Medical Systems Ltd., among others.

The post Global Telemedicine Market Research Report – Global Forecast Till 2023 first appeared on CRI Report.

Keen to monetize their vast wireless network assets, mobile operators view mHealth as a substantial revenue opportunity – and many are extending beyond providing pure connectivity services, towards end-to-end mHealth offerings such as remote patient monitoring.

mHealth also offers a wealth of opportunities to the pharmaceutical industry, ranging from accelerated clinical trial innovation and medication adherence monitoring to securing the supply chain and combating counterfeit drugs. In addition, with the increasing prevalence of mobile apps that provide therapeutic impact, the digital therapeutics space is beginning to emerge, which may one day rival mainstream pharmaceuticals in areas such as chronic disease care.

Other stakeholders that are set to benefit from mHealth include but are not limited to connected medical and wearable device OEMs, app developers, Big Data and analytics specialists, cloud computing giants, and even ride-hailing providers such as Uber and Lyft – whose platforms are increasingly being integrated with healthcare IT systems, letting healthcare providers improve their level of care by booking rides for their patients.

Driven by the thriving ecosystem, SNS Telecom & IT estimates that the mHealth market will account for more than $28 Billion in 2018 alone. Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Telecom & IT estimates further growth at a CAGR of approximately 30% over the next three years.

The “mHealth (Mobile Healthcare) Ecosystem: 2018 – 2030 – Opportunities, Challenges, Strategies & Forecasts“ report presents an in-depth assessment of the mHealth ecosystem including market drivers, challenges, enabling technologies, applications, key trends, standardization, regulatory landscape, case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for mHealth investments from 2018 till 2030. The forecasts are segmented for 5 submarkets, 29 use case categories, 5 ecosystem player categories, 6 geographical regions and 34 countries.

The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.

Topics Covered
The report covers the following topics:
– The scope and implementation of mHealth across the globe
– mHealth technology
– Market drivers and key benefits of mHealth
– Challenges and inhibitors to the mHealth ecosystem
– mHealth standardization and regulatory initiatives
– mHealth opportunities, use cases and applications
– mHealth deployment case studies
– Value chain analysis of the mHealth ecosystem and the recognition of key players in each segment of the value chain
– mHealth future roadmap: 2018 – 2030
– Key trends in the mHealth ecosystem: cloud-based mHealth services, digital medicine, connected drug delivery, population health management, regulatory developments, and the impact of LTE/5G networks.
– The role of IoT and wearable technology in the mHealth ecosystem
– Profiles and strategies of over 310 leading and emerging mHealth ecosystem players
– Strategic recommendations for mobile operators, enabling technology providers, mHealth device OEMs, application developers, healthcare service providers and pharmaceutical companies
– In-depth analysis for 5 individual submarkets and their associated mHealth application use cases:
○ Pharmaceutical Applications
○ Medical Information & Healthcare Management
○ Healthcare & Fitness
○ Remote Consultation/Diagnostic Services
○ IoT, Wearable Technology, Sensor & Monitoring Applications
– Market analysis and forecasts from 2018 till 2030

Forecast Segmentation
Market forecasts are provided for each of the following 5 submarkets and their 23 use case categories:

Pharmaceutical Applications
– Safety Data Collection
– Consumer Education
– Medical Education
– Post–Market Monitoring
– Drug Authentication
– Social Media
– Patient Compliance & Retention: Clinical Trials

Information & Healthcare Management
– Electronic Health/Medical Records & Tracking Tools
– Diagnostic Tools & Medical Reference
– Continuing Medical Education
– Awareness Through Alerts
– Logistical & Payment Support

Healthcare & Fitness
– Medical Compliance
– Fitness & Nutrition Apps
– Clinical Decision Support Systems
– Prescribable Mobile Apps

Remote Consultation/Diagnostic Services
– Mobile Video Consultations, Collaboration & Surgery
– Non-Video Consultations & Collaboration
– Remote Collaboration in Emergency Situations

IoT, Wearable Technology, Sensor & Monitoring Applications
– Health and Wellness Monitoring
– Disease Surveillance/Remote Monitoring
– Diagnostic Tools
– Technical Logistics

Revenue is also split by ecosystem player:

Ecosystem Player Segmentation
– Mobile Operators & Connectivity Providers
– Mobile & mHealth Device OEMs
– Content & Application Providers
– Healthcare Service Providers
– Pharmaceutical Industry
– The following regional and country markets are also covered:

Regional Markets
– Asia Pacific
– Eastern Europe
– Latin & Central America
– Middle East & Africa
– North America
– Western Europe

Country Markets
– Argentina, Australia, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, India, Indonesia, Israel, Italy, Japan, Malaysia, Mexico, Norway, Pakistan, Philippines, Poland, Qatar, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, UAE, UK, USA

Additional forecasts are provided for the following:
– IoT connections for mHealth applications
– Health and fitness-centric wearable device shipments
– Mobile video calling users
– Annual throughput of mobile network data traffic
– Smartphone, feature phone, tablet, desktop PC and notebook shipments
– Mobile network subscriptions by region
– Cost saving potential of mHealth by region
– Big Data & analytics technology investments in the healthcare sector

Key Questions Answered
The report provides answers to the following key questions:
– How big is the mHealth opportunity?
– What trends, challenges and barriers are influencing its growth?
– How is the ecosystem evolving by segment and region?
– What will the market size be in 2021 and at what rate will it grow?
– Which regions and countries will see the highest percentage of growth?
– How is the mHealth value chain structured and how will it evolve overtime?
– What level of cost savings can mHealth facilitate for healthcare service providers in each region?
– What will be the installed base of IoT connections for mHealth applications in 2021?
– How many mHealth-centric wearable devices will be shipped in 2021?
– Are digital therapeutics a threat to the pharmaceutical industry?
– What are the key applications of LTE and 5G networks in the mHealth arena?
– What considerations should be taken into account to devise a successful mHealth strategy for hospitals and other healthcare delivery environments?
– Who are the key ecosystem players and what are their strategies?
– What strategies should mobile operators, enabling technology providers, mHealth device OEMs, healthcare service providers, pharmaceutical companies and application developers adopt to capitalize on the mHealth opportunity?

Key Findings
The report has the following key findings:
– Driven by the thriving ecosystem, SNS Telecom & IT estimates that the mHealth market will account for more than $28 Billion in 2018 alone. Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Telecom & IT estimates further growth at a CAGR of approximately 30% over the next three years.
– With ongoing advances in key enabling technologies such as the miniaturization of sensors and the development of 5G NR (New Radio) platforms, a spate of new applications are beginning to emerge – ranging from connected drug delivery platforms to UHD (Ultra High Definition) video streaming for remote medical examinations.
– SNS Telecom & IT estimates that annual unit shipments of health and fitness-centric wearable devices will surpass 105 Million by the end of 2018. In order to gain valuable insights from the data generated by these devices, healthcare providers and other stakeholders are increasingly investing in Big Data and analytics technology.
– As key stakeholders realize the revenue potential of mHealth, a spate of prominent strategic partnerships are beginning to emerge. For example, pharmaceutical giant Novartis has recently partnered with digital therapeutics specialist Pear Therapeutics to co-develop prescription mobile apps aimed at treating patients with multiple sclerosis, schizophrenia and substance use disorder.

The post The mHealth (Mobile Healthcare) Ecosystem: 2018 – 2030 – Opportunities, Challenges, Strategies & Forecasts first appeared on CRI Report.